Daily non-political popular news in brief.
Rochester study rolls out RU-486 to treat uterine fibroids
12-06-2006 · EurekAlert!Low doses of the drug mifepristone shrink uterine fibroid tumors and greatly improve the quality of life in women who suffer from pain and heavy bleeding, according to a University of Rochester study published in the December Obstetrics and Gynecology journal.
Read more »
Keywords: rochester, study, rolls, ru-486, treat, uterine, fibroids, roll, 486, fibroid
« Previous | Next »
Similar news on "Rochester study rolls out RU-486 to treat uterine fibroids":
- Focused ultrasound relieves fibroid symptoms in women
05-29-2007 · EurekAlert!
A noninvasive ultrasound procedure effectively shrinks uterine fibroids and significantly relieves fibroid-related symptoms in women, according to the results of a multicenter clinical trial reported in the June issue of the journal Radiology. Magnetic resonance-guided, focused ultrasound surgery (MRgFUS) allows radiologists to precisely target fibroids without harming healthy surrounding tissue.
Similar news · Read more »
- Children would need different medical care in wake of dirty bomb
10-30-2007 · EurekAlert!
If terrorists were to attack with a dirty bomb, medical authorities should be prepared to treat children differently than adults because their developing bodies would absorb and respond to the radiation exposure in distinct ways, according to a new study from the University of Rochester Medical Center.
Similar news · Read more »
- Mayo Clinic study finds focused ultrasound treatment of uterine fibroids long term symptom relief
07-31-2007 · EurekAlert!
A noninvasive, outpatient treatment for noncancerous uterine tumors provides sustained relief from symptoms, according to a new Mayo Clinic led collaborative study.
Similar news · Read more »
- Revlimid data presented at ASCO stands to change the way physicians treat multiple myeloma
06-04-2007 · EurekAlert!
Findings from a Phase III study by the Eastern Cooperative Oncology Group (ECOG) were presented yesterday at the American Society of Clinical Oncology (ASCO) meeting in Chicago and demonstrate the impressive survival benefits of using Revlimid (lenalidomide) with reduced doses of the steroid dexamethasone.
Similar news · Read more »
- Anti-obesity drug may prevent and treat obesity-related liver disease
07-02-2007 · EurekAlert!
A new study on the effect of the anti-obesity drug rimonabant on liver function in obese rats found that it reduced markers of liver damage, decreased levels of pro-inflammatory proteins, and improved lipid profiles.
Similar news · Read more »
- Video games shown to improve vision
03-15-2007 · EurekAlert!
According to a new study from the University of Rochester, playing action video games sharpens vision. In tests of visual acuity that assess the ability to see objects accurately in a cluttered space, game players scored higher than their non-playing peers.
Similar news · Read more »
- Study suggests existing drugs may be useful in treating brain tumors
10-15-2007 · EurekAlert!
Scientists have shown how developing brain tumors can turn an encounter with a signaling molecule from a fatal experience for the tumor cells into a cue for their own growth and multiplication. The transformation relies on two molecules that can be modified with existing drugs, opening the possibility of using them to treat brain tumors.
Similar news · Read more »
- Anti-hypertensive drugs may help prevent and treat Alzheimer's disease
10-25-2007 · EurekAlert!
A new study has identified commonly prescribed drugs for the treatment of hypertension may be capable of preventing Alzheimer's disease and cognitive deterioration.
Similar news · Read more »
- Penn's Abramson Cancer Center part of major phase III study for myeloma
11-21-2007 · EurekAlert!
Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
Similar news · Read more »
- Firefly genes allow testing of new therapy against lymphoma
12-19-2007 · EurekAlert!
Researchers here have figured out a way to use a firefly gene to let them see just how effective a new drug combination actually is against some forms of cancer and its serious complication. The new study looked at ATLL, adult T cell lymphoma and leukemia, a form of cancer where it is particularly hard to gauge the disease's progress, and where the patients' prognosis is generally poor. There is now no widely effective therapy available to treat this disease successfully.
Similar news · Read more »
